fellowship also fosters early career development support.
The candidate will lead innovative research projects in drug development for toxin envenomation, including mechanistic actions, structure-activity relationships, and preclinical assessment.
Upon successful application, you will be hosted in Monash University Malaysia (Dr Michelle Yap – Toxin Pharmacology Lab) for 2 years and 1 year at Lancaster University (Dr Steve R Hall).
Eligibility:
- Must hold a PhD in pharmacology, toxinology, biomedical science, biochemistry or biology-related field at the time of application.
- Meets MSCA requirements for this Global Fellowship: The applicant must be national or long-term resident (5 years+) of an EU Member State or Horizon Europe Associated Country.
- Demonstrates an excellent track record of publications.
- Demonstrates proficiency in research, laboratory, and data analysis skills; bioinformatics knowledge is an added advantage.
- Demonstrates proficiency in writing and communication skills
- Demonstrates ability to work effectively in a team.
To express interest, please submit a CV, and motivation to apply with two recommendation letters from academic supervisors or collaborators. We will contact the shortlisted candidate to prepare for the application.
Closing Date for Applications:
To allow ample preparation time for application and proposal writing, we anticipate the closing date to be 9 July 2026. However, please note that the call will remain open until a suitable candidate is found. Early submissions are encouraged.
Contact:
For more information, please contact Dr Steve R Hall (s.r.hall@lancaster.ac.uk) or Dr Michelle Yap (yap.michelle@monash.edu).
